Mineral water as non-medicamentous way in treatment of irritable bowel syndrome (IBS)
https://doi.org/10.21518/2079-701X-2018-3-70-77
Abstract
This article on irritable bowel syndrome (IBS) focuses on the definition, epidemiology and pathophysiology as a means of understanding optimal treatment strategies, considered more standard and new methods of treating IBS.
Keywords
About the Authors
V. V. SkvortsovRussian Federation
MD, Prof.
M. V. Lunkov
Russian Federation
PhD in medicine
A. V. Kulinich
Russian Federation
E. M. Skvortsova
Russian Federation
PhD in medicine
A. V. Morozov
Russian Federation
Candidate of Agricultural Sciences
A. R. Starova
Russian Federation
A. A. Mironov
Russian Federation
References
1. Grigoryev PYa, Yakovenko YaP. Compositional disorder of normal intestinal microflora, clinical significance and therapy issues: a methodical guide. M., 2000. 16 p.
2. Ivashkin VT. Irritable bowel syndrome. A practical guide for practitioners. Moscow: RGA, 1999.
3. Grigoryev PYa, Yakovenko YaP. Lactulose for the treatment of digestive system diseases. Rossiyskiy Gastroenterol. Zhurnal, 2000, 2: 71-78.
4. Zaprudnov AM, Mazankova LN. Intestinal microbial flora and probiotics. Prilozhenie k Zhurnalu Pediatriya, 1999, 4: 48.
5. Skvortsova EM, Skvortsov VV. Revisiting the diagnosis and treatment of irritable bowel syndrome. Terapevt, 2015, 5-6: 41-49.
6. Skvortsov VV. Intestinal dysbiosis and antibiotic-associated diarrhea. Lechashchiy Vrach, 2008, 2: 43-47.
7. Skvortsov VV, Skvortsova EM. Diagnosis and treatment of irritable bowel syndrome. Meditsinskiy Alfavit. Prakticheskaya Gastroenterologiya, 2015, 7(248): 25-31
8. Trukhan DI. Functional gastrointestinal disorders: therapeutic potential of curative mineral water. Meditsinskiy Sovet, 2017, 5.
9. Zakharova IN, Tvorogova TM, Orovikt EB. Therapeutic mineral water: from the past to the future. Meditsinskiy Sovet, 2015, 14.
10. Pogorelova AS. The role of DonatMg mineral water in therapeutic practice. Meditsinskiy Sovet, 2017, 3.
11. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology, 2002, 123: 450–460.
12. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut, 1999, 45: II43–II47.
13. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology, 2006, 130: 1480–1491.
14. Ford AC, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology, 2013, 145: 1262–1270.
15. Kruis W, Thieme C, Weinzierl M, Schüssler P, Holl J, Paulus W. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology, 1984, 87: 1–7.
Review
For citations:
Skvortsov VV, Lunkov MV, Kulinich AV, Skvortsova EM, Morozov AV, Starova AR, Mironov AA. Mineral water as non-medicamentous way in treatment of irritable bowel syndrome (IBS). Meditsinskiy sovet = Medical Council. 2018;(3):70-77. (In Russ.) https://doi.org/10.21518/2079-701X-2018-3-70-77